COSCIENS Biopharma Inc. Impairment Loss Recognised In Profit Or Loss Goodwill
COSCIENS Biopharma Inc. (CSCIF) reported Impairment Loss Recognised In Profit Or Loss Goodwill of $7.64 million for the 12-month period ending 2022-12-31, per its 20-F/A filed 2024-07-17.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill · last filed 2024-07-17
| Period end | Impairment Loss Recognised In Profit Or Loss Goodwill 12 month |
|---|---|
| 2022-12-31 | $7.64M 20-F/A · filed 2024-07-17 |
| 2021-12-31 | $0.00 20-F · filed 2022-03-29 |